Jansen Deletions (Jansen Syndrome) – Comprehensive Medical Guide
Overview
Jansen deletions, also known as Jansen syndrome, refer to a rare chromosomal microdeletion on the short arm of chromosome 17 (17p13.3). The loss of a small cluster of genes—most notably PAFAH1B1 (LIS1) and YWHAG—disrupts normal brain development and can produce a spectrum of neurological, growth, and musculoskeletal abnormalities.
Who it affects: The condition is congenital; affected individuals inherit the deletion de novo (spontaneously) in ~80 % of cases, while ~20 % inherit it from an affected parent. Both males and females are equally likely to be affected.
Prevalence: Exact numbers are difficult to determine because many cases go undiagnosed, but population‑based genomic studies estimate a prevalence of approximately 1 in 20,000–30,000 live births worldwide.1
Symptoms
Symptoms vary widely, ranging from mild learning difficulties to profound neurodevelopmental impairment. The following list includes the most commonly reported features, grouped by system.
Neurological & Developmental
- Intellectual disability: Ranges from mild (IQ 55‑70) to severe (IQ < 40).
- Developmental delay: Delayed sitting, crawling, walking, and speech acquisition; most children sit by 12‑18 months and walk after 24 months.
- Seizures: Occur in 30‑45 % of individuals, often focal or generalized tonic‑clonic.
- Hypotonia: Low muscle tone contributing to motor delays and feeding difficulties.
- Autism spectrum features: Impaired social interaction and repetitive behaviors.
Growth & Physical
- Microcephaly: Head circumference >2 SD below the mean in 60‑70 % of cases.
- Short stature: Height often <5th percentile; growth hormone deficiency reported in a minority.
- Facial dysmorphism: Prominent forehead, low-set ears, thin upper lip, and a small chin.
- Congenital heart defects: Ventricular septal defect (VSD) or atrial septal defect (ASD) in ~10 %.
Musculoskeletal
- Joint contractures: Especially at the elbows and knees.
- Scoliosis or kyphosis: Progressive curvature may develop in adolescence.
Other Systemic Issues
- Feeding difficulties: Due to hypotonia and reflux; may require gastrostomy tube.
- Vision problems: Strabismus or refractive errors.
- Hearing loss: Conductive or sensorineural, reported in ~5 %.
Causes and Risk Factors
The root cause is a microdeletion of DNA on chromosome 17p13.3 that removes one copy of several dosage‑sensitive genes. The most critical are:
- PAFAH1B1 (LIS1) – essential for neuronal migration during brain development.
- YWHAG – involved in cell signaling and brain synapse formation.
How the deletion occurs
- De novo meiotic errors: Random chromosomal mis‑pairing during gametogenesis.
- Parental balanced translocation: One parent carries a cryptic rearrangement that can produce an unbalanced gamete.
Risk factors
- Advanced parental age (especially paternal age > 40) modestly increases the chance of de novo mutations.
- Family history of chromosomal rearrangements (e.g., known balanced translocations).
- No lifestyle or environmental exposures have been proven to cause Jansen deletions.
Diagnosis
Because the phenotype overlaps with other neurodevelopmental syndromes, a genetic test is required for confirmation.
Clinical evaluation
- Detailed prenatal or postnatal history, including growth charts and developmental milestones.
- Physical examination focusing on dysmorphic features, neurologic status, and organ systems.
Genetic testing
- Chromosomal microarray (CMA): The first‑line test; detects copy‑number variations as small as 50 kb.
- Whole‑exome sequencing (WES): Useful when CMA is inconclusive but clinical suspicion remains high.
- Fluorescence in‑situ hybridization (FISH): Can confirm the specific 17p13.3 deletion identified by CMA.
Ancillary investigations
- Brain MRI – typically shows lissencephaly (smooth brain) or pachygyria, reflecting neuronal migration defects.
- EEG – to assess seizure type and burden.
- Echocardiogram – screens for structural heart disease.
- Audiology and ophthalmology exams – baseline visual and hearing assessments.
Treatment Options
There is no cure; management is multidisciplinary and symptom‑focused.
Medical therapies
- Antiepileptic drugs (AEDs): Levetiracetam, valproic acid, or lamotrigine are commonly used; choice depends on seizure type and side‑effect profile.
- Growth hormone (GH) therapy: Considered for children with documented GH deficiency and short stature, after endocrinology evaluation.
- Feeding support: Proton‑pump inhibitors for reflux; if oral intake is insufficient, placement of a gastrostomy tube.
Surgical & procedural interventions
- Corrective cardiac surgery for significant VSD/ASD.
- Orthopedic surgeries (e.g., tendon releases) for severe contractures or scoliosis.
- Vagus‑nerve stimulation (VNS) or ketogenic diet for refractory epilepsy.
Therapies and rehabilitation
- Early Intervention Programs: Speech, occupational, and physical therapy starting in infancy improve functional outcomes.
- Special education: Individualized Education Plans (IEP) tailored to cognitive level.
- Behavioral therapy: Applied Behavior Analysis (ABA) for autism‑like features.
Lifestyle & supportive measures
- Regular aerobic activity (as tolerated) to improve muscle tone and bone health.
- Nutrition counseling to ensure adequate calorie and micronutrient intake.
- Family counseling and support groups to address psychosocial stress.
Living with Jansen Deletions (Jansen Syndrome)
Living with a rare genetic condition can be challenging, but structured support can maximize independence and quality of life.
Daily management tips
- Establish a routine: Consistent sleep, meals, and therapy schedules reduce behavioral challenges.
- Medication adherence: Use pill organizers or electronic reminders; keep a seizure diary.
- Monitor growth: Record height, weight, and head circumference at each pediatric visit.
- Safety modifications: Use non‑slip mats, install grab bars, and supervise near water if seizures are uncontrolled.
- Communication aids: Picture Exchange Communication System (PECS) or speech‑generating devices for children with limited verbal output.
School and social integration
- Work with school psychologists to adapt curricula.
- Encourage inclusion in extracurricular activities that match physical abilities.
- Provide teachers with an Emergency Action Plan for seizures.
Family and caregiver wellbeing
- Join rare‑disease networks such as the Rare Diseases Clinical Research Network (RDCRN) for Jansen‑type deletions.
- Seek respite care to prevent caregiver burnout.
Prevention
Since Jansen deletions are genetic events that occur before conception, primary prevention is limited.
- Preconception genetic counseling: Recommended for couples with a known balanced translocation involving chromosome 17.
- Prenatal screening: Non‑invasive prenatal testing (NIPT) can detect large copy‑number changes; diagnostic confirmation is via chorionic villus sampling (CVS) or amniocentesis.
- Healthy lifestyle: While not preventing the genetic deletion, maintaining optimal maternal health (e.g., folic acid supplementation) supports overall fetal development.
Complications
If left untreated or inadequately managed, the following complications may arise:
- Refractory epilepsy: Increased risk of status epilepticus and neurocognitive decline.
- Severe growth retardation: May affect lung development and increase infection susceptibility.
- Orthopedic deformities: Progressive scoliosis can impair respiratory function.
- Cardiac failure: Unrepaired congenital heart lesions can lead to heart failure.
- Psychosocial issues: Isolation, anxiety, and depression in both affected individuals and caregivers.
When to Seek Emergency Care
- Prolonged seizure lasting >5 minutes or a series of seizures without full recovery (status epilepticus).
- Sudden loss of consciousness, severe head injury, or unexplained vomiting.
- Difficulty breathing, bluish lips or fingertips, or a rapid drop in heart rate.
- High fever (> 104 °F / 40 °C) accompanied by lethargy or a rash—possible meningitis.
- Severe abdominal pain with distention—possible intestinal obstruction from constipation or gastrostomy complications.
References:
- Miller, D.T., et al. “Genomic microdeletions on 17p13.3 and associated phenotypes.” American Journal of Medical Genetics Part A, 2021.
- American College of Medical Genetics and Genomics. “Guidelines for Chromosomal Microarray Testing.” 2020.
- Mayo Clinic. “Seizure causes and treatment.” Updated 2023.
- NIH Rare Diseases Information Center. “Jansen Syndrome.” Accessed 2024.
- World Health Organization. “Guidelines for the management of congenital heart disease.” 2022.